|
ZNF107 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.282800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.125000E-01 |
| Normal-vs-Stage2 |
2.957000E-01 |
| Normal-vs-Stage3 |
4.046800E-01 |
| Normal-vs-Stage4 |
8.475600E-02 |
| Stage1-vs-Stage2 |
2.952000E-01 |
| Stage1-vs-Stage3 |
3.585000E-01 |
| Stage1-vs-Stage4 |
4.246100E-02 |
| Stage2-vs-Stage3 |
5.826400E-01 |
| Stage2-vs-Stage4 |
8.915000E-01 |
| Stage3-vs-Stage4 |
3.060200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.684200E-01 |
| Normal-vs-AfricanAmerican |
5.233000E-01 |
| Normal-vs-Asian |
4.899900E-02 |
| Caucasian-vs-AfricanAmerican |
9.773800E-01 |
| Caucasian-vs-Asian |
1.879640E-01 |
| AfricanAmerican-vs-Asian |
1.769810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.513000E-01 |
| Normal-vs-Female |
6.467000E-01 |
| Male-vs-Female |
3.803800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.219820E-01 |
| Normal-vs-Age(41-60Yrs) |
2.158600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.985600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.807440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.448400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.069820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.000400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.738800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.923600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.999500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.871600E-01 |
| Normal-vs-Grade 2 |
3.357400E-01 |
| Normal-vs-Grade 3 |
7.954600E-01 |
| Normal-vs-Grade 4 |
1.705980E-01 |
| Grade 1-vs-Grade 2 |
6.455600E-01 |
| Grade 1-vs-Grade 3 |
2.851800E-01 |
| Grade 1-vs-Grade 4 |
8.599400E-01 |
| Grade 2-vs-Grade 3 |
3.652200E-01 |
| Grade 2-vs-Grade 4 |
4.986600E-01 |
| Grade 3-vs-Grade 4 |
1.827030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.909600E-01 |
| Normal-vs-ccB subtype |
3.624200E-02 |
| ccA subtype-vs-ccB subtype |
3.661800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.556400E-01 |
| Normal-vs-N1 |
4.764500E-02 |
| N0-vs-N1 |
4.716400E-02 |
|
|
